Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0RZ0N
|
||||
Former ID |
DIB010341
|
||||
Drug Name |
FR-62765
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Terminated | [529820] | ||
Company |
Fujisawa Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H18O5
|
||||
Canonical SMILES |
C1(=C(C(=O)OC1CCC(=O)OCC)OC)c1ccccc1
|
||||
CAS Number |
CAS 105346-34-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Modulator | [529820] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.